PAUL CANE PATHOLOGY LIMITED

Company Registration Number:
07962042 (England and Wales)

Unaudited micro entity accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

PAUL CANE PATHOLOGY LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

PAUL CANE PATHOLOGY LIMITED

Company Information

for the Period Ended 31 March 2025




Registered office: 39
Fernwood Avenue
London
England
SW16 1RD
Company Registration Number: 07962042 (England and Wales)

PAUL CANE PATHOLOGY LIMITED

Profit and Loss Account

for the Period Ended 31 March 2025


2025
£

2024
£
Turnover 750 0
Income from coronavirus (COVID-19) business support grants - 0
Other Income - 0
Cost of Materials ( 173 ) ( 411 )
Staff Costs - ( 0 )
Depreciation and Writeoffs - ( 0 )
Other charges - ( 0 )
Tax on Profit - ( 0 )
Profit or (Loss) for Period 577 ( 411 )

PAUL CANE PATHOLOGY LIMITED

Balance sheet

As at 31 March 2025


2025
£

2024
£
Current assets: 14,272 13,376
Net current assets (liabilities): 14,272 13,376
Total assets less current liabilities: 14,272 13,376
Total net assets (liabilities): 14,272 13,376
Capital and reserves: 14,272 13,376

PAUL CANE PATHOLOGY LIMITED

Balance sheet continued

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 31 December 2025
And Signed On Behalf Of The Board By:

Name: Paul Cane
Status: Director

The notes form part of these financial statements

PAUL CANE PATHOLOGY LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Employee Information

    Average number of employees: 0

PAUL CANE PATHOLOGY LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Off balance sheet disclosure

    No